Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Carroll

Showing results (1-10 of 126) with videos related to

Pageof 13
Sort By:
Haematologica|February 4, 2021
Understanding how retinoic acid derivatives induce differentiation in non-M3 acute myelogeneous leukemiaMartin Carroll
Blood|August 22, 2009
Taking aim at protein translation in AMLMartin Carroll
Blood|June 30, 2012
BCR/ABL and chromosomal instability: debate resolvedMartin Carroll
Cancer Biology & Therapy|March 19, 2003
Beyond directed therapeutics--are two drugs always better than one?Martin Carroll
Immunological Reviews|December 17, 2014
When cancer and immunology meetMartin Carroll
Blood|July 24, 2020
A common protein target for an uncommon subtype of AMLMartin Carroll
The Journal of Clinical Investigation|December 16, 2010
BCR-ABL kinase is dead; long live the CML stem cellAlexander Perl, Martin Carroll
Cancer Biology & Therapy|February 21, 2004
Signaling, drugs and apoptosis of myeloma cellsMartin Carroll, Charles S Abrams
The New England Journal of Medicine|May 29, 2009
A common genetic mechanism in malignant bone marrow diseasesRoss L Levine, Martin Carroll
Current Treatment Options in Oncology|December 22, 2007
Exploiting signal transduction pathways in acute myelogenous leukemiaAlexander E Perl, Martin Carroll
Pageof 13

Showing results (1-10 of 126) with videos related to

Sort By:
Pageof 13
Haematologica|February 4, 2021
Understanding how retinoic acid derivatives induce differentiation in non-M3 acute myelogeneous leukemiaMartin Carroll
Blood|August 22, 2009
Taking aim at protein translation in AMLMartin Carroll
Blood|June 30, 2012
BCR/ABL and chromosomal instability: debate resolvedMartin Carroll
Cancer Biology & Therapy|March 19, 2003
Beyond directed therapeutics--are two drugs always better than one?Martin Carroll
Immunological Reviews|December 17, 2014
When cancer and immunology meetMartin Carroll
Blood|July 24, 2020
A common protein target for an uncommon subtype of AMLMartin Carroll
The Journal of Clinical Investigation|December 16, 2010
BCR-ABL kinase is dead; long live the CML stem cellAlexander Perl, Martin Carroll
Cancer Biology & Therapy|February 21, 2004
Signaling, drugs and apoptosis of myeloma cellsMartin Carroll, Charles S Abrams
The New England Journal of Medicine|May 29, 2009
A common genetic mechanism in malignant bone marrow diseasesRoss L Levine, Martin Carroll
Current Treatment Options in Oncology|December 22, 2007
Exploiting signal transduction pathways in acute myelogenous leukemiaAlexander E Perl, Martin Carroll
Pageof 13